| rs1062746 |
chr16 |
87364650 |
0.000002 |
T |
C |
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy) |
FBXO31 |
UTR-3 |
24554482
|
| rs11117267 |
chr16 |
87386375 |
0.0006915 |
T |
C |
Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) |
FBXO31 |
intron |
23233654
|
| rs11117267 |
chr16 |
87386375 |
0.000692 |
T |
C |
Methotrexate clearance (acute lymphoblastic leukemia) |
FBXO31 |
intron |
23233662
|
| rs10779242 |
chr16 |
87386517 |
0.000623 |
A |
G |
Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) |
FBXO31 |
intron |
23233654
|
| rs10779242 |
chr16 |
87386517 |
0.000623 |
A |
G |
Methotrexate clearance (acute lymphoblastic leukemia) |
FBXO31 |
intron |
23233662
|
| rs10779243 |
chr16 |
87386754 |
0.00068 |
A |
G |
Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) |
FBXO31 |
intron |
23233654
|
| rs10779243 |
chr16 |
87386754 |
0.00068 |
A |
G |
Methotrexate clearance (acute lymphoblastic leukemia) |
FBXO31 |
intron |
23233662
|
| rs8043667 |
chr16 |
87387765 |
0.0008387 |
A |
T |
Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) |
FBXO31 |
intron |
23233654
|
| rs8043667 |
chr16 |
87387765 |
0.000839 |
A |
T |
Methotrexate clearance (acute lymphoblastic leukemia) |
FBXO31 |
intron |
23233662
|
| rs11646004 |
chr16 |
87389001 |
0.0007415 |
C |
T |
Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) |
FBXO31 |
intron |
23233654
|
| rs11646004 |
chr16 |
87389001 |
0.000742 |
C |
T |
Methotrexate clearance (acute lymphoblastic leukemia) |
FBXO31 |
intron |
23233662
|
| rs1834022 |
chr16 |
87394386 |
0.00044 |
A |
G |
Prostate cancer |
FBXO31 |
intron |
23555315
|
| rs11645617 |
chr16 |
87409266 |
0.0008598 |
T |
C |
Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) |
FBXO31 |
intron |
23233654
|
| rs11645617 |
chr16 |
87409266 |
0.00086 |
T |
C |
Methotrexate clearance (acute lymphoblastic leukemia) |
FBXO31 |
intron |
23233662
|
| rs11649260 |
chr16 |
87409288 |
0.0008565 |
G |
A |
Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) |
FBXO31 |
intron |
23233654
|
| rs11649260 |
chr16 |
87409288 |
0.000857 |
G |
A |
Methotrexate clearance (acute lymphoblastic leukemia) |
FBXO31 |
intron |
23233662
|
| rs8054103 |
chr16 |
87420182 |
0.000916 |
G |
A |
Methotrexate clearance (acute lymphoblastic leukemia) |
FBXO31 |
intron |
23233662
|
| rs750956 |
chr16 |
87420769 |
0.0000924 |
G |
A |
Multiple complex diseases |
FBXO31 |
intron |
17554300
|